375 related articles for article (PubMed ID: 8084431)
41. Pulmonary involvement in progressive systemic sclerosis: sequential evaluation with CT, pulmonary function tests, and bronchoalveolar lavage.
Remy-Jardin M; Remy J; Wallaert B; Bataille D; Hatron PY
Radiology; 1993 Aug; 188(2):499-506. PubMed ID: 8327704
[TBL] [Abstract][Full Text] [Related]
42. Bronchoalveolar lavage for evaluation and management of scleroderma disease of the lung.
Behr J; Vogelmeier C; Beinert T; Meurer M; Krombach F; König G; Fruhmann G
Am J Respir Crit Care Med; 1996 Aug; 154(2 Pt 1):400-6. PubMed ID: 8756813
[TBL] [Abstract][Full Text] [Related]
43. Interstitial lung disease in systemic sclerosis.
Kaloudi O; Miniati I; Alari S; Matucci-Cerinic M
Intern Emerg Med; 2007 Dec; 2(4):250-5. PubMed ID: 18172592
[TBL] [Abstract][Full Text] [Related]
44. Pulmonary veno-occlusive disease and the CREST variant of scleroderma.
Morassut PA; Walley VM; Smith CD
Can J Cardiol; 1992 Dec; 8(10):1055-8. PubMed ID: 1288837
[TBL] [Abstract][Full Text] [Related]
45. Evidence for oesophageal and anorectal involvement in very early systemic sclerosis (VEDOSS): report from a single VEDOSS/EUSTAR centre.
Lepri G; Guiducci S; Bellando-Randone S; Giani I; Bruni C; Blagojevic J; Carnesecchi G; Radicati A; Pucciani F; Marco MC
Ann Rheum Dis; 2015 Jan; 74(1):124-8. PubMed ID: 24130266
[TBL] [Abstract][Full Text] [Related]
46. [Generalized sclerosis (scleroderma) in children].
Martínez-Cordero E; López-Zepeda J; Martínez-Miranda E; Reyes-Salinas A; Negrete-García MC
Bol Med Hosp Infant Mex; 1989 Oct; 46(10):641-8. PubMed ID: 2695112
[TBL] [Abstract][Full Text] [Related]
47. HRCT and scleroderma: semiquantitative evaluation of lung damage and functional abnormalities.
Bellia M; Cannizzaro F; Scichilone N; Riili M; Triolo G; Midiri M; Lagalla R
Radiol Med; 2009 Mar; 114(2):190-203. PubMed ID: 19266260
[TBL] [Abstract][Full Text] [Related]
48. Fibrosing alveolitis in systemic sclerosis. Bronchoalveolar lavage findings in relation to computed tomographic appearance.
Wells AU; Hansell DM; Rubens MB; Cullinan P; Haslam PL; Black CM; Du Bois RM
Am J Respir Crit Care Med; 1994 Aug; 150(2):462-8. PubMed ID: 8049830
[TBL] [Abstract][Full Text] [Related]
49. [Collageno-vascular diseases and interstitial pulmonary fibrosis. An analysis of diagnostic tests].
Baldi S; Rapellino M; Libertucci D; Obert R; Scappaticci E; Coni F; Revello F; Oliaro A; Botto-Micca F
Minerva Med; 1987 Sep; 78(17):1277-80. PubMed ID: 3670681
[TBL] [Abstract][Full Text] [Related]
50. [Pulmonary involvement in primary Sjogren syndrome].
González Ruiz JM; García-Satue JL; Díaz Lobato S; Esteban Calvo R; Villasante C
An Med Interna; 1994 May; 11(5):232-4. PubMed ID: 8061138
[TBL] [Abstract][Full Text] [Related]
51. Cyclophosphamide pulse regimen in the treatment of alveolitis in systemic sclerosis.
Giacomelli R; Valentini G; Salsano F; Cipriani P; Sambo P; Conforti ML; Fulminis A; De Luca A; Farina G; Candela M; Generini S; De Francisci A; Tirri E; Proietti M; Bombardieri S; Gabrielli A; Tonietti G; Cerinic MM
J Rheumatol; 2002 Apr; 29(4):731-6. PubMed ID: 11950014
[TBL] [Abstract][Full Text] [Related]
52. HRCT and pulmonary function tests in monitoring of lung involvement in juvenile systemic sclerosis.
Panigada S; Ravelli A; Silvestri M; Granata C; Magni-Manzoni S; Cerveri I; Dore R; Tomà P; Martini A; Rossi GA; Sacco O
Pediatr Pulmonol; 2009 Dec; 44(12):1226-34. PubMed ID: 19911363
[TBL] [Abstract][Full Text] [Related]
53. A longitudinal study of pulmonary involvement in primary Sjögren's syndrome: relationship between alveolitis and subsequent lung changes on high-resolution computed tomography.
Salaffi F; Manganelli P; Carotti M; Baldelli S; Blasetti P; Subiaco S; Binci MC; Bichi Secchi E; Amici F; Cervini C
Br J Rheumatol; 1998 Mar; 37(3):263-9. PubMed ID: 9566665
[TBL] [Abstract][Full Text] [Related]
54. Comprehensive investigation of novel serum markers of pulmonary fibrosis associated with systemic sclerosis and dermato/polymyositis.
Kumánovics G; Minier T; Radics J; Pálinkás L; Berki T; Czirják L
Clin Exp Rheumatol; 2008; 26(3):414-20. PubMed ID: 18578962
[TBL] [Abstract][Full Text] [Related]
55. Antinuclear antibodies as immunologic markers for a benign subset and different clinical characteristics of scleroderma.
Kleinsmith DM; Heinzerling RH; Burnham TK
Arch Dermatol; 1982 Nov; 118(11):882-5. PubMed ID: 6753766
[TBL] [Abstract][Full Text] [Related]
56. The differing patterns of interstitial lung involvement in connective tissue diseases.
Cairns D; Shelley L; Burke WM; Bryant DH; Yeates M; Penny R; Breit SN
J Rheumatol; 1992 Jul; 19(7):1089-95. PubMed ID: 1512763
[TBL] [Abstract][Full Text] [Related]
57. Systemic sclerosis: using high-resolution CT to detect lung disease in children.
Seely JM; Jones LT; Wallace C; Sherry D; Effmann EL
AJR Am J Roentgenol; 1998 Mar; 170(3):691-7. PubMed ID: 9490955
[TBL] [Abstract][Full Text] [Related]
58. Cardio-pulmonary involvement in systemic sclerosis: A study at a tertiary care center.
Arakkal G; Chintagunta SR; Chandika V; Damarla SV; Manchala S; Kumar BU
Indian J Dermatol Venereol Leprol; 2017; 83(6):677-682. PubMed ID: 29035287
[TBL] [Abstract][Full Text] [Related]
59. Lung impairment in scleroderma.
Piorunek T; Kuznar-Kaminska B; Cofta S; Batura-Gabryel H; Poplawski D; Majewski D; Puszczewicz M; Wysocka E
Adv Exp Med Biol; 2013; 755():149-54. PubMed ID: 22826062
[TBL] [Abstract][Full Text] [Related]
60. Restrictive lung disease in pregnancy.
King TE
Clin Chest Med; 1992 Dec; 13(4):607-22. PubMed ID: 1478021
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
